Evidence map›Paper›PMID 40323396›Full record

ArticleArchives of gynecology and obstetrics2025

The Pre-Twin Screen Consortium proposal for fetal structural anomalies evaluation across all three trimesters in twin pregnancies.

R Svirsky, R Maymon, N Kugler, A Orenstein, N Z Sharon, A Sharabi-Nov, H Meiri, M Maslenko, R Brown, H Portillo-Rodrigue and 16 more

Abstract readMulticenter Study
In one paragraph

Article in Archives of gynecology and obstetrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

R SvirskyDepartment of Obstetrics and Gynecology, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel. rsvirs@gmail.com.
R MaymonDepartment of Obstetrics and Gynecology, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.
N KuglerDepartment of Obstetrics and Gynecology, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.
A OrensteinDepartment of Obstetrics and Gynecology, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.
N Z SharonDepartment of Obstetrics and Gynecology, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.
A Sharabi-NovTel Hai Academic College, Israel and Ziv Medical Center, Safed, Israel.
H MeiriDepartment of Obstetrics and Gynecology, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.
M MaslenkoMedical Genetic Unit, Department of Obstetrics and Gynecology, Samson Assuta Ashdod University Hospital, Ashdod, Israel.
R BrownDivision of Maternal Fetal Medicine, Department of Obstetrics & Gynaecology, McGill University Health Centre, Montreal, Canada.
H Portillo-RodrigueDivision of Maternal Fetal Medicine, Department of Obstetrics & Gynaecology, McGill University Health Centre, Montreal, Canada.
A GoncéHospital Clínic of Barcelona, BCNatal, Materno-Fetal Medicine Center, Barcelona, Spain.
M BennasarHospital Clínic of Barcelona, BCNatal, Materno-Fetal Medicine Center, Barcelona, Spain.
I MatasHospital Clínic of Barcelona, BCNatal, Materno-Fetal Medicine Center, Barcelona, Spain.
A GeipelDepartment of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
A WalterDepartment of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
C SimoniniDepartment of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
B StrizekDepartment of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
E BevilacquaDepartment of Obstetrics and Gynecology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
E TorciaDepartment of Obstetrics and Gynecology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
K O KaganMaternal Fetal Medicine Unit, Department of Obstetrics and Gynecology, University Hospital Tubingen, Tubingen, Germany.
J SteinerMaternal Fetal Medicine Unit, Department of Obstetrics and Gynecology, University Hospital Tubingen, Tubingen, Germany.
T LennartzMaternal Fetal Medicine Unit, Department of Obstetrics and Gynecology, University Hospital Tubingen, Tubingen, Germany.
A BauerMaternal Fetal Medicine Unit, Department of Obstetrics and Gynecology, University Hospital Tubingen, Tubingen, Germany.
K H NicolaidesFetal Medicine Research Institute, King's College Hospital, London, UK.
A BorrellHospital Clínic of Barcelona, BCNatal, Materno-Fetal Medicine Center, Barcelona, Spain.
PreTwin Screen Consortium

Funding

BMBF Bundesministerium für Bildung und Forschung. DLR Deutsches Zentrum für Luft- und Raumfahrt 01KU2001CIHR ENP-168103Departament de Salut, Generalitat de Catalunya SLD001/19/000002Erapermed project JTC2019-61Fonds de Recherche du Québec - Santé FRSQ # 294417Israel Ministry of Health 16874
6 · The paper itself

Abstract

purposeIn singleton pregnancies, routine ultrasound examinations in each trimester improves the diagnosis of fetal abnormalities and their management. In this study, we examine twin pregnancies and report on the detection of fetal anomalies in each trimester and postnatally as well as on the type of anomalies and their prevalence.

methodsThis prospective multicenter study enrolled pregnant women with dichorionic (DC) and monochorionic diamniotic (MCDA) twins at gestational weeks (GA) 11 + 0 to 13 + 6 in six medical centers (two in Germany, and one each in Spain, Canada, Italy, and Israel). Pregnancies were dated by the crown-rump length of the larger twin. Detailed scans were performed according to the guidelines of the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) at enrollment at gestational week (GA) 11 + 0 to 13 + 6, and at GA 20 + 0 to 22 + 6 and GA 28 + 0 to 32 + 6. Neonatal examinations were conducted in each case. Malformations were confirmed after delivery or postmortem in cases of fetal death or termination of pregnancy (TOP).

resultsOf the 649 twin pregnancies (1298 live fetuses) at enrollment, there were 436 (70.6%) DC and 182 (29.4%) MCDA pregnancies. In total, 1168 babies were liveborn to 618 mothers (808 DC and 360 MCDA twins) after excluding cases lost to follow-up and TOPs. Anomalies were identified in 4.1% of the fetuses (48/1168). Of the 48 fetuses with anomalies, 17 (35.4%) were identified in the first, 21 (43.8%) in the second, and 6 (12.5%) in the third trimester. Additional 4 (8.3%) were identified postnatally. Of the anomalies, 37 were in fetuses from DC twins (4.57%), and 11 (3.05%) in MCDA twins.

conclusionWe demonstrate the utility of detailed fetal scans in twin pregnancies in all three trimesters. First- and second-trimester diagnosis enables genetic counseling and testing, and informed parental decisions of pregnancy management. In addition to alerting the parents to the presence of fetal anomalies, third-trimester scans enhanced delivery planning and newborn care.

Indexed as

Congenital AbnormalitiesPregnancy, TwinUltrasonography, PrenatalAdultFemaleGestational AgeHumansInfant, NewbornPregnancyPregnancy TrimestersProspective StudiesDetection rateFirst-trimester scanMalformationsThird-trimester scanTwin pregnancy

Identifiers

PMID40323396
PMCPMC12334499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.